Overview

PCC vs. FFP for Post Cardiopulmonary Bypass Coagulopathy and Bleeding

Status:
Enrolling by invitation
Trial end date:
2022-01-01
Target enrollment:
Participant gender:
Summary
This will be the first prospective randomized controlled clinical trial directly comparing Prothrombin Complex Concentrate (PCC) Compared to Fresh Frozen Plasma (FFP) for post cardiopulmonary bypass microvascular bleeding and factor-mediated coagulopathy. Is there a difference in bleeding and transfusion requirements in patients received PCC versus FFP?
Phase:
Phase 4
Details
Lead Sponsor:
Mayo Clinic
Collaborator:
CSL Behring
Treatments:
Thrombin